Intricon names medical device veteran as CFO

11 Oct 2023
www.medicaldesignandoutsourcing.com
Executive Change
NEWS RELEASE: Intricon names medical device veteran as CFO ST. PAUL, Minn. (Oct. 11, 2023) — Intricon , developer and manufacturer of medical devices powered by smart miniaturized electronics, today announced that it has named Shaun Blakeman as its chief financial officer (CFO) and newest member of its executive team. “Shaun is a seasoned global financial executive with 25+ years of operational and broad business experience as well as a proven record of results-driven impact,” said Scott Longval, Intricon chief executive officer. “I am confident we will benefit from Shaun’s leadership as we continue to transform the organization to drive enhanced growth, innovation, and value for our customers.” Scott added that Shaun was selected given his deep understanding of the medical device industry and his expertise in finance for global businesses. He also has a proven track record in operations, logistics, engineering project management, and managing high-performing technical teams. Most recently, Shaun was CFO at SomaLogic. He also served as CFO for Cantel Medical, now part of Steris, and in senior financial positions at Medtronic and IDEX Corporation. Shaun is a veteran of the U.S Navy, serving as an officer at sea and managing large technical projects. He earned an MBA from Indiana University’s Kelley School of Business, a master’s degree in applied physics from the Naval Postgraduate School, and an economics degree from the University of Minnesota. “I am excited to join Intricon during this important period in the company’s transformation,” said Shaun. “Intricon is well-positioned to drive meaningful growth in its sensor-driven medical device business. I look forward to partnering closely with the leadership team and finance organization to enhance Intricon’s unique value proposition and execute its growth strategy.” About Intricon The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.